BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 21720513)

  • 1. Research progress on siRNA delivery with nonviral carriers.
    Gao Y; Liu XL; Li XR
    Int J Nanomedicine; 2011; 6():1017-25. PubMed ID: 21720513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small Interfering RNAs and their Delivery Systems: A Novel Powerful Tool for the Potential Treatment of HIV Infections.
    Bolhassani A; Milani A
    Curr Mol Pharmacol; 2020; 13(3):173-181. PubMed ID: 31760929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticle-based delivery system for application of siRNA in vivo.
    Wang Y; Li Z; Han Y; Liang LH; Ji A
    Curr Drug Metab; 2010 Feb; 11(2):182-96. PubMed ID: 20359287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
    Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A
    Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab.
    Höbel S; Koburger I; John M; Czubayko F; Hadwiger P; Vornlocher HP; Aigner A
    J Gene Med; 2010 Mar; 12(3):287-300. PubMed ID: 20052738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonviral in vivo delivery of therapeutic small interfering RNAs.
    Aigner A
    Curr Opin Mol Ther; 2007 Aug; 9(4):345-52. PubMed ID: 17694447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient siRNA delivery with non-viral polymeric vehicles.
    Kim WJ; Kim SW
    Pharm Res; 2009 Mar; 26(3):657-66. PubMed ID: 19015957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinspired tumor-homing nanoplatform for co-delivery of paclitaxel and siRNA-E7 to HPV-related cervical malignancies for synergistic therapy.
    Xu C; Liu W; Hu Y; Li W; Di W
    Theranostics; 2020; 10(7):3325-3339. PubMed ID: 32194871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy.
    Miele E; Spinelli GP; Miele E; Di Fabrizio E; Ferretti E; Tomao S; Gulino A
    Int J Nanomedicine; 2012; 7():3637-57. PubMed ID: 22915840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cationic nanosystems for the delivery of small interfering ribonucleic acid therapeutics: a focus on toxicogenomics.
    Akhtar S
    Expert Opin Drug Metab Toxicol; 2010 Nov; 6(11):1347-62. PubMed ID: 20929276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent progress in chemically modified siRNAs.
    Gaglione M; Messere A
    Mini Rev Med Chem; 2010 Jun; 10(7):578-95. PubMed ID: 20500149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hollow Inorganic Nanoparticles as Efficient Carriers for siRNA Delivery: A Comprehensive Review.
    Varshosaz J; Taymouri S
    Curr Pharm Des; 2015; 21(29):4310-28. PubMed ID: 26323421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing.
    Cardoso AL; Simões S; de Almeida LP; Pelisek J; Culmsee C; Wagner E; Pedroso de Lima MC
    J Gene Med; 2007 Mar; 9(3):170-83. PubMed ID: 17351968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-targeted delivery of siRNA by non-viral vector: safe and effective cancer therapy.
    Chen Y; Huang L
    Expert Opin Drug Deliv; 2008 Dec; 5(12):1301-11. PubMed ID: 19040393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SiRNA delivery: challenges and role of carrier systems.
    Shegokar R; Al Shaal L; Mishra PR
    Pharmazie; 2011 May; 66(5):313-8. PubMed ID: 21699063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposome based systems for systemic siRNA delivery: stability in blood sets the requirements for optimal carrier design.
    Buyens K; De Smedt SC; Braeckmans K; Demeester J; Peeters L; van Grunsven LA; de Mollerat du Jeu X; Sawant R; Torchilin V; Farkasova K; Ogris M; Sanders NN
    J Control Release; 2012 Mar; 158(3):362-70. PubMed ID: 22023849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanocarrier Mediated siRNA Delivery Targeting Stem Cell Differentiation.
    Fernandes F; Kotharkar P; Chakravorty A; Kowshik M; Talukdar I
    Curr Stem Cell Res Ther; 2020; 15(2):155-172. PubMed ID: 31789134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifunctional pH-Sensitive Amino Lipids for siRNA Delivery.
    Gujrati M; Vaidya A; Lu ZR
    Bioconjug Chem; 2016 Jan; 27(1):19-35. PubMed ID: 26629982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Degradable polyethylenimines as DNA and small interfering RNA carriers.
    Jere D; Jiang HL; Arote R; Kim YK; Choi YJ; Cho MH; Akaike T; Cho CS
    Expert Opin Drug Deliv; 2009 Aug; 6(8):827-34. PubMed ID: 19558333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient and targeted delivery of siRNA in vivo.
    Shim MS; Kwon YJ
    FEBS J; 2010 Dec; 277(23):4814-27. PubMed ID: 21078116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.